z-logo
open-access-imgOpen Access
Reproducible and scalable purification of extracellular vesicles using combined bind-elute and size exclusion chromatography
Author(s) -
Giulia Corso,
Imre Mäger,
Yi Lee,
André Görgens,
Jarred J. Bultema,
Bernd Giebel,
Matthew Wood,
Joel Z. Nordin,
Samir El Andaloussi
Publication year - 2017
Publication title -
scientific reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.24
H-Index - 213
ISSN - 2045-2322
DOI - 10.1038/s41598-017-10646-x
Subject(s) - extracellular vesicles , flow cytometry , size exclusion chromatography , elution , microvesicles , nanoparticle tracking analysis , chemistry , ultracentrifuge , chromatography , vesicle , extracellular , cell , affinity chromatography , extracellular vesicle , microbiology and biotechnology , biophysics , biology , biochemistry , membrane , enzyme , microrna , gene
Extracellular vesicles (EVs) play a pivotal role in cell-to-cell communication and have been shown to take part in several physiological and pathological processes. EVs have traditionally been purified by ultracentrifugation (UC), however UC has limitations, including resulting in, operator-dependant yields, EV aggregation and altered EV morphology, and moreover is time consuming. Here we show that commercially available bind-elute size exclusion chromatography (BE-SEC) columns purify EVs with high yield (recovery ~ 80%) in a time-efficient manner compared to current methodologies. This technique is reproducible and scalable, and surface marker analysis by bead-based flow cytometry revealed highly similar expression signatures compared with UC-purified samples. Furthermore, uptake of eGFP labelled EVs in recipient cells was comparable between BE-SEC and UC samples. Hence, the BE-SEC based EV purification method represents an important methodological advance likely to facilitate robust and reproducible studies of EV biology and therapeutic application.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here